US tuberculosis diagnosis and treatment market is anticipated to grow at a CAGR around -0.2% during the forecast period. Though, tuberculosis (TB) is a preventable as well as curable disease, too many people in US still suffers from it. Centre of Disease Control and Prevention (CDC) plays a crucial role in TB elimination in the country. It works with state and local partners toward the goal of TB elimination. Moreover, it collects TB surveillance data to track national progress towards elimination and inform TB prevention and control activities. The US Agency for International Development (USAID) is the lead implementing agency for the country’s global TB efforts. All US TB efforts have been coordinated under the international working group of the Federal Tuberculosis Task Force. 

Visit for Global Tuberculosis Diagnosis and Treatment Market Report at: https://www.omrglobal.com/industry-reports/tuberculosis-diagnosis-and-treatment-market-size

Additionally, the US partners with international institutions for supporting global TB funding mechanisms. Moreover, US are the largest donor to the Global Fund and it has committed around $5.9 billion in funding for TB programs globally. Furthermore, it is one of the largest donors to the Global Drug Facility which is a mechanism of the Stop TB Partnership that provides grants to countries for TB drugs. Their key partners are WHO and the Stop TB Partnership. Moreover, the country supports TB activities through several other agencies including CDC, NIH and OGAC & DoD. 

US tuberculosis diagnosis and treatment market is segmented on the basis of drugs type and diagnosis. Based on drug type, the market is segmented into first line drugs and second line drugs. Based on diagnosis, the market is segmented into laboratory testing, nucleic acid amplification test, mantoux test, radiography and drug susceptibility testing. 

The key players that are active in the market include Abbott Laboratories, Akonni Biosystems, Inc., Alere Inc., Becton, Dickinson and Co., Cepheid, Inc, Hologic, Inc., Johnson & Johnson, Novartis AG, Pfizer Inc. and Thermo Fisher Scientific.

Research Methodology

The market study of the US Tuberculosis Diagnosis and Treatment market is incorporated by extensive primary and secondary research conducted by the research team at OMR.  Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macro-economic factors. Numbers extracted from Secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings authenticity to our reports.

Secondary Sources Include

• Financial reports of companies involved in the market.
• Whitepapers, research-papers, and news blogs.
• Company websites and their product catalog.

The report provides an in-depth analysis of market size, intended quality of the service preferred by consumers. The report will serve as a source for a 360-degree analysis of the market thoroughly integrating different models.

Market Segmentation

1. US Tuberculosis Diagnosis and Treatment  Market Research and Analysis by Drugs Type
2. US Tuberculosis Diagnosis and Treatment Market Research and Analysis by Diagnosis

The Report Covers

• Comprehensive research methodology of the US Tuberculosis Diagnosis and Treatment market.
• This report also includes a detailed and extensive market overview with key analyst insights.
• An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
• Analysis of regional regulations and other government policies impacting the US Tuberculosis Diagnosis and Treatment market.
• Insights about market determinants which are stimulating the US Tuberculosis Diagnosis and Treatment market.
• Detailed and extensive market segments with regional distribution of forecasted revenues.
• Extensive profiles and recent developments of market players.